Herbalife Ltd. income statement HLF

Annual Quarterly

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Herbalife Ltd. reported revenue of $1.4 billion, up 6.0% from the same quarter a year earlier. Net income was $58.8 million, a profit margin of 4.4%. Operating income came to $138.5 million, an operating margin of 10.3%. Diluted earnings per share were $0.55.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
5,277
+6.4%
1,350
+6.0%
1,327
+5.4%
1,317
+7.8%
1,283
+6.3%
1,274
+2.7%
1,259
-1.7%
1,222
-3.4%
1,207
-0.6%
Cost of revenue
1,182
+8.0%
306
+7.7%
296
+7.0%
291
+9.8%
288
+7.8%
284
+5.8%
277
-2.2%
265
-6.9%
268
-7.0%
Gross profit
4,095
+5.9%
1,044
+5.5%
1,030
+4.9%
1,026
+7.3%
995
+5.8%
990
+1.8%
982
-1.6%
956
-2.3%
940
+1.3%
Selling, general and administrative
—
906
+102.3%
902
+101.4%
893
+106.8%
—
448
+0.8%
448
-10.8%
432
-12.3%
437
-7.9%
Other operating income (expense)
6
+3.8%
0
0
-100.0%
6
0
-100.0%
0
-100.0%
5
—
0
+400.0%
Restructuring and impairment
2
-61.4%
0
-100.0%
0
-100.0%
0
-100.0%
2
+144.4%
1
-70.4%
1
-98.6%
3
-80.2%
1
Operating expenses
—
906
902
888
—
—
—
—
—
Operating income
505
+3.5%
138
+10.1%
128
-3.2%
138
+12.7%
100
-6.3%
126
-1.0%
133
+64.9%
123
+70.8%
106
+90.9%
Interest expense
174
-21.9%
32
-37.5%
37
-30.2%
47
-10.0%
58
-12.7%
51
-9.7%
54
-7.1%
52
+37.2%
66
+33.5%
Other non-operating income (expense)
-95
0
-95
—
0
0
0
—
0
Pretax income
245
-11.6%
107
+42.5%
-4
-104.7%
92
+29.4%
50
-4.0%
75
+5.9%
79
+547.5%
71
+108.2%
53
+197.2%
Income tax
68
+256.9%
50
+56.2%
23
-23.5%
30
+49.0%
-35
+72.4%
32
+36.6%
30
+297.3%
20
+110.3%
-125
-1770.7%
Net income
180
-44.0%
59
+36.1%
-26
-153.3%
62
+22.8%
85
-52.0%
43
-8.9%
49
+948.9%
50
+107.4%
178
+1644.1%
Basic EPS
1.73
-45.0%
0.56
+33.3%
-0.25
-152.1%
0.60
+20.0%
0.83
-53.0%
0.42
-10.6%
0.48
+860.0%
0.50
+108.3%
1.76
+1611.4%
Diluted EPS
1.68
-46.1%
0.55
+31.0%
-0.25
-152.1%
0.57
+16.3%
0.82
-53.2%
0.42
-8.7%
0.48
+860.0%
0.49
+104.2%
1.74
+1620.2%
Weighted average shares, basic
104
+1.9%
105
+1.7%
104
+1.8%
104
+2.3%
103
+2.2%
103
+2.4%
103
+2.1%
102
+1.8%
101
+1.9%
Weighted average shares, diluted
107
+3.9%
107
+3.2%
104
+1.2%
108
+6.1%
105
+2.5%
104
+2.1%
103
+1.6%
102
+1.5%
102
+1.4%
Other measures
Depreciation and amortization
121
-0.2%
30
-0.7%
31
+3.0%
29
-4.2%
29
+1.0%
31
+0.3%
30
-6.4%
31
+5.1%
29
+2.8%
EBITDA
626
+2.8%
169
+8.0%
160
-2.1%
168
+9.3%
129
-4.7%
156
-0.8%
163
+44.3%
154
+51.8%
136
+61.3%
Interest coverage
2.90x
4.34x
3.43x
2.96x
1.73x
2.47x
2.47x
2.36x
1.61x
Margins
Gross margin
77.61%
77.33%
77.67%
77.90%
77.53%
77.69%
78.01%
78.29%
77.84%
Operating margin
9.57%
10.26%
9.67%
10.51%
7.78%
9.88%
10.53%
10.05%
8.82%
Pretax margin
4.64%
7.90%
-0.28%
6.95%
3.94%
5.87%
6.27%
5.80%
4.36%
Profit margin
3.41%
4.35%
-1.98%
4.70%
6.66%
3.39%
3.92%
4.13%
14.73%
EBITDA margin
11.85%
12.52%
12.04%
12.74%
10.06%
12.29%
12.95%
12.56%
11.22%
Effective tax rate
27.80%
46.44%
—
33.19%
-68.51%
42.38%
37.72%
28.81%
-238.21%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
HLF (NYSE)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
George Town, Cayman Islands
SEC filer status
Large accelerated filer
SEC CIK
1180262
Former names
HERBALIFE NUTRITION LTD. (until Apr 11, 2023); WH HOLDINGS CAYMAN ISLANDS LTD (until Dec 13, 2004)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.